| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 318.399 | 742.150 | 943.616 |
| Total Income - EUR | - | - | - | - | - | - | - | 331.967 | 753.755 | 987.361 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 351.901 | 676.486 | 814.619 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -19.934 | 77.270 | 172.742 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -22.358 | 67.532 | 147.476 |
| Employees | - | - | - | - | - | - | - | 7 | 10 | 10 |
Check the financial reports for the company - Phoenix Diagnostic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 930.316 | 858.081 | 837.483 |
| Current Assets | - | - | - | - | - | - | - | 82.966 | 107.728 | 206.811 |
| Inventories | - | - | - | - | - | - | - | 11.243 | 8.563 | 7.623 |
| Receivables | - | - | - | - | - | - | - | 42.668 | 72.440 | 143.578 |
| Cash | - | - | - | - | - | - | - | 29.055 | 26.725 | 55.610 |
| Shareholders Funds | - | - | - | - | - | - | - | -22.317 | 45.282 | 147.525 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 1.035.805 | 920.868 | 898.078 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Phoenix Diagnostic S.r.l.